
Danaher Corporation DHR
$ 173.58
0.98%
Annual report 2025
added 02-24-2026
Danaher Corporation Operating Expenses 2011-2026 | DHR
Annual Operating Expenses Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 6.71 B | 7.7 B | 7.17 B | 6.58 B | 7.29 B | 7.01 B | 6.68 B | 6.32 B | 5.63 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.7 B | 5.63 B | 6.79 B |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
222 M | $ 17.69 | 3.39 % | $ 544 M | ||
|
Guardant Health
GH
|
226 M | $ 118.57 | -0.32 % | $ 14.9 B | ||
|
Interpace Biosciences
IDXG
|
20 M | $ 1.8 | -1.1 % | $ 7.96 M | ||
|
Agilent Technologies
A
|
1.99 B | $ 115.56 | 0.56 % | $ 35.1 B | ||
|
Celcuity
CELC
|
172 M | $ 133.57 | -3.37 % | $ 6.25 B | ||
|
Illumina
ILMN
|
3.69 B | $ 145.36 | 0.66 % | $ 23.1 B | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
50.6 M | $ 9.53 | 87.97 % | $ 12.7 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 19.78 | -1.84 % | $ 573 M | ||
|
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
411 M | $ 21.54 | -0.42 % | $ 1.15 B | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 100.91 | -2.03 % | $ 6.81 B | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 114.93 | -1.59 % | $ 9.48 B | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 106.36 | 0.31 % | $ 22.8 B | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
430 M | $ 9.26 | 0.33 % | $ 1.19 B | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
National Research Corporation
NRC
|
38.5 M | $ 18.98 | -0.52 % | $ 425 M | ||
|
Natera
NTRA
|
258 M | $ 200.53 | -1.31 % | $ 19.7 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 157.22 | -1.92 % | $ 7.79 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Personalis
PSNL
|
44.5 M | $ 9.06 | 6.91 % | $ 809 M | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
118 M | $ 429.95 | -0.66 % | $ 12.4 B | ||
|
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
964 M | $ 3.85 | 0.65 % | $ 357 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 26.89 | -0.22 % | $ 25.5 B | ||
|
Senseonics Holdings
SENS
|
61.8 M | $ 6.44 | 1.61 % | $ 269 M | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
181 M | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
116 M | $ 64.78 | 6.94 % | $ 3.87 B | ||
|
Biomerica
BMRA
|
5.64 M | $ 2.47 | -1.0 % | $ 5.67 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 259.82 | -0.07 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
7.15 B | $ 449.78 | 0.36 % | $ 170 B | ||
|
Waters Corporation
WAT
|
687 M | $ 342.76 | 0.11 % | $ 20.4 B | ||
|
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.65 | 7.14 % | $ 233 M | ||
|
Motus GI Holdings
MOTS
|
19.1 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 9.06 | 1.74 % | $ 1.97 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 193.42 | -0.92 % | $ 21.5 B |